رياتاز ١٥٠ ملغ
Country: Israel
Language: Arabic
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ATAZANAVIR AS SULFATE 150 MG
Available from:
BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED
ATC code:
J05AE08
Pharmaceutical form:
CAPSULES
Administration route:
PER OS
Manufactured by:
BRISTOL MAYERS SQUIBB COMPANY , USA
Therapeutic group:
ATAZANAVIR
Therapeutic indications:
Reyataz is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Authorization date:
2009-05-01
